Stock·NASDAQ·Utilities
Exelon Corp (EXC)
- Market cap
- $46.05B
- P/E
- 16.43
- Dividend yield
- 3.71%
- Street target
- $48.00median of 22 analysts
- 52-week range
- $39.73 $50.65
EXC stock forecast today
Where EXC stands today, and what CleaRank Financial AI makes of it.
EXC at a glance
Exelon Corp (EXC): Buy, 68/100 on CleaRank's AI score.
- Trend Mixed: the price is above its 50-day but below its 200-day moving average ($42.83 and $45.57).
- Earnings EXC beat estimates in 7 of its last 8 quarters, yet fell the next day after 5 of those beats.
- Valuation P/E of 16.4 against 22.8 for the Utilities sector: a discount to peers (-28%).
Figures as of October 27, 2026.
CleaRank Financial AI
Exelon Corp (EXC) earns a CleaRank rating of Buy and a model score of 68/100.
The biggest lift comes from valuation, where the P/E of 16.43 is 27.9% below the sector median, a discount to peers, and the P/S of 1.81 is 45.2% below the sector median. Trend pulls the score down the most. The price is 1.91% below its 200-day average, and that average sits above the 50-day, which is 6.01% below it. The 50-day stands at $42.83 and the 200-day at $45.57. Across the past year, the price has fallen 7.01%.
Only on CleaRank
Figures we compute ourselves from EXC's own price, earnings and insider-filing history. Tap one to see it in context.
EXC stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
1/4Price above its 50-day average ›
The price of $44.70 is 4.4% above the 50-day simple moving average of $42.83.Price above its 200-day average ›
The price is 1.9% below the 200-day simple moving average of $45.57.50-day average above the 200-day ›
The 50-day average ($42.83) is 6.0% below the 200-day average ($45.57), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 46% of its 52-week range, between $39.73 and $50.65.
EXC share price
Pick a period: each tab shows how far EXC has moved over it, to the last close.
Today's trading
Where EXC sits inside today's range and its 52-week range.
EXC fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
5/5P/E below the sector median ›
The trailing P/E of 16.43 is 27.9% below the Utilities median of 22.8.P/S below the sector median ›
The price-to-sales ratio of 1.81 is 45.2% below the sector median of 3.3.Profitable over the last 12 months ›
Net income over the last 12 months was $2.8B on revenue of $25.3B, a net margin of 11.0%.Beat estimates in most recent reports ›
EXC beat the EPS estimate in 7 of its last 8 reports.Pays a dividend ›
The trailing dividend yield is 3.71%, or $1.66 a share a year.
Key statistics
The headline figures for EXC.
As of October 27, 2026, EXC trades at $44.70, with a market value of $46.05B, a P/E ratio of 16.43 and a dividend yield of 3.71%.
What the numbers say
CleaRank Financial AI's reading of EXC's valuation, growth and risks.
EXC trades at 16.43 times trailing earnings, which places it 27.9% below the Utilities median of 22.8. The peer comparison on this page treats that as a discount to peers. Trailing earnings of $2.72 a share give that multiple its base.
EXC is outgrowing its sector: year on year, revenue rose 9.90% in the latest quarter, compared with a sector median of 4.1%. Profitability is solid, with a net margin of 10.99%, an operating margin of 16.59% and a return on equity of 9.71%, which is above the sector median of 9.6%. On the balance sheet, debt-to-equity stands at 1.77, and the trailing dividend yield is 3.71%, equal to $1.66 a share each year.
EXC's most recent report, on July 30, 2026, missed the estimate by 4.44%, with EPS of $0.43 against an estimate of $0.45. The market reacted the other way, with the stock rising 0.53% the following session.
EXC has beaten estimates in 7 of the last 8 reports, yet the stock fell after 5 of those 7 beats, with the share price lower in the next session. For this fiscal year, analysts average an EPS estimate of $2.86, implying growth of 3.1%. Next year's average estimate is $3.03, a rise of 6.2%.
On an average day, EXC's share price moves 1.32%, and its beta against the S&P 500 stands at 0.40.
EXC against the Utilities sector
How EXC compares with the median Utilities stock CleaRank tracks.
Price to earnings vs sector: EXC trades at a notable discount to sector peers (-28%), which may indicate undervaluation or specific company headwinds.
Return vs XLU: Since May 15, 2025, EXC has gained 2.9% against a gain of 5.8% for XLU.
Performance against XLU
EXC and the Utilities sector fund over the same days.
Revenue and earnings
How much EXC sells, and how much of it becomes profit.
Revenue growth: Revenue grew 5.3% in FY2025 to $24.3B, from $23.0B a year earlier.
Profit margin: The net margin was 11.4% in FY2025, up from 10.7% the year before.
Profitable: EXC earned $2.8B in FY2025.
Earnings reality check
Did EXC beat what analysts expected, and how did the stock react?
Earnings record: EXC beat the analyst estimate in 7 of the last 8 quarters.
Market reaction: The stock fell in the first session after 5 of those 7 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 30, 2026after close | $0.45 | $0.43 | -4.44% | +0.53% | -0.57% |
| May 6, 2026after close | $0.89 | $0.91 | +2.25% | -1.35% | -1.67% |
| Feb 12, 2026after close | $0.55 | $0.59 | +7.27% | +1.96% | +0.50% |
| Nov 4, 2025after close | $0.78 | $0.86 | +10.26% | -0.50% | -2.03% |
| Jul 31, 2025after close | $0.37 | $0.39 | +5.41% | -0.60% | +1.34% |
| May 1, 2025after close | $0.86 | $0.92 | +6.98% | -0.26% | -3.22% |
| Feb 12, 2025after close | $0.59 | $0.64 | +8.47% | +0.19% | +0.65% |
| Oct 30, 2024after close | $0.67 | $0.71 | +5.97% | -1.01% | -3.48% |
As of October 27, 2026, EXC has beaten the analyst EPS estimate in 7 of its last 8 reported quarters and fell in the first trading session after 5 of those beats; its latest report, on July 30, 2026, came in 4.44% below the estimate and the stock moved +0.53% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
EXC AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
3/3RSI not overbought or oversold ›
The 14-day RSI is 65.9, showing bullish momentum without being overbought.RSI above 50 ›
An RSI of 65.9 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank Financial AI analysis of EXC
The score, the reasoning behind it, and what could move the price next.
Exelon Corp (EXC) shows a split trend picture. At $44.70, the stock is 4.37% above its 50-day average of $42.83, yet 1.91% below its 200-day average of $45.57. The 50-day average itself sits 6.01% below the 200-day, so the longer average still carries more weight. Over the past year, the price is 12.51% above the 52-week low of $39.73 and 11.75% below the 52-week high of $50.65.
Recent gains sit against a weaker longer record: the price rose 10.81% over the past month, fell 5.52% over the past three months and fell 7.01% over the past year. The 14-day RSI of 65.9 is in the bullish zone, below the overbought line, and the MACD line is positive.
Analyst upgrade ›
Keybanc upgraded it to Sector Weight from Underweight on October 13, 2026.
Source: Analyst action, Keybanc, October 13, 2026
Earnings miss, but the stock rose ›
The July 30, 2026 report missed the EPS estimate by 4.44%, and the share price rose 0.53% in the first session after it.
Source: Earnings report, July 30, 2026New analyst coverage ›
HSBC started coverage at Hold on October 22, 2026.
Source: Analyst action, HSBC, October 22, 2026
- Two levels deserve the closest attention. The 200-day SMA, at $45.57, sits above the price, while the 20-day EMA, at $43.04, sits below it.
- With the 14-day RSI at 65.9, momentum reads as bullish, and the MACD line is positive. Readings above 70 or below 30 signal stretched momentum.
- EXC gained 0.53% in the first session after the July 30, 2026 report. Across the last 8 reports, it beat estimates in 7.
The trend is mixed: EXC is above its 50-day average at $42.83 but below its 200-day average at $45.57. A close above the 200-day would turn both signals up, and a close below the 50-day would turn both down. The nearest levels are the 20-day EMA at $43.04 below and the 200-day SMA at $45.57 above.
With the RSI in the bullish zone, momentum remains on the side of the current move.
Technical indicators
Momentum and trend for EXC, from its daily closes.
As of October 27, 2026, with EXC at $44.70, its 14-day RSI is 65.9 (showing bullish momentum without being overbought), its 50-day simple moving average is $42.83 and its 200-day is $45.57.
Calculated by CleaRank on daily closes as of October 27, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What EXC moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 27, 2026, EXC's 1-year correlation of daily returns is -0.06 with S&P 500 (SPY), -0.18 with Nasdaq 100 (QQQ), -0.07 with Bitcoin (BTC) and +0.00 with gold (XAU).
EXC price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
1/3Most analysts rate it a buy ›
4 of 22 analysts rate it a buy or strong buy, 17 a hold and 1 a sell.Median target above the price ›
The median 12-month target of $48.00 is 7.4% above the price.More buy ratings than three months ago ›
4 of 22 rate it a buy now, against 4 of 22 three months ago.
EXC Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 22, 2026 | HSBC | Initiates | Hold |
| Oct 21, 2026 | Morgan Stanley | Maintains | Equal-Weight |
| Oct 19, 2026 | JP Morgan | Maintains | Neutral |
| Oct 19, 2026 | Barclays | Maintains | Equal-Weight |
| Oct 16, 2026 | Truist Securities | Maintains | Hold |
| Oct 13, 2026 | Keybanc | Upgrade | Sector Weight |
As of October 27, 2026, 22 Wall Street analysts cover EXC: 4 rate it a buy or strong buy, 17 a hold and 1 a sell or strong sell. Their 12-month price targets range from $44.00 to $58.00. The median EXC price target is $48.00, 7.4% above the price of $44.70.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
EXC trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
EXC trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from EXC's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much EXC tends to move, against the market and on its own.
EXC price history and drawdowns
EXC's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
3/4Average daily move under 2% ›
The price has moved 1.32% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 30.7%, from February 2020 to May 2020, regained by July 2021.Most 1-year holds ended higher ›
74% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $29,362, against $42,015 in the S&P 500 (SPY).
EXC Drawdowns & Recovery
As of October 27, 2026, EXC's worst peak-to-trough fall over the last 10 years with dividends reinvested was -30.7% (February 2020 to May 2020); it regained that peak by July 2021, 14 months after the low, and 74% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into EXC in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: EXC trailed the S&P 500 over this period: $29,362 against $42,015.
A $10,000 investment in EXC in October 2016 would be worth about $29,362 today with dividends reinvested, compared with about $42,015 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to EXC, and which have not.
Strongest month, October: an average of +4.11%, up in 6 of 9 years.
Weakest month, September: an average of -2.25%, up in 4 of 10 years.
This month, October: has averaged +4.11%, up in 6 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, EXC's strongest calendar month has been October (average +4.11%, up in 6 of 9 years) and its weakest September (average -2.25%, up in 4 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
EXC stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in EXC, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in EXC today could grow to about $12,808 by 2030 in the base case, with a 90th-percentile outcome near $23,722 and a 10th-percentile outcome around $6,915. The simulation models price only; at today's 3.71% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
EXC Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $57.25 for EXC by 2030 in the base case, from $44.70 today (1.3x over 4 years). The 10th-percentile path ends near $30.91. These are outcomes of a Monte Carlo simulation run on EXC's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $34.94 | $47.55 | $64.72 | |
| 2028 | $32.72 | $50.59 | $78.22 | |
| 2029 | $31.56 | $53.82 | $91.78 | |
| 2030 | $30.91 | $57.25 | $106 |
Method: a lognormal simulation of EXC's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
EXC insider trading
What the people running the company have bought and sold.
EXC insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Insider trading: No insider bought EXC shares on the open market in the last 18 months.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Mar 31, 2026 | William Paul Bowers
Director
|
Grant | 878 | $43.7K |
| Mar 31, 2026 | Marjorie Rodgers Cheshire
Director
|
Grant | 878 | $43.7K |
| Mar 31, 2026 | David G Dewalt
Director
|
Grant | 878 | $43.7K |
| Mar 31, 2026 | Linda P Jojo
Director
|
Grant | 878 | $43.7K |
| Mar 31, 2026 | Charisse R Lillie
Director
|
Grant | 878 | $43.7K |
| Mar 31, 2026 | Anna S. Richo
Director
|
Grant | 878 | $43.7K |
| Mar 31, 2026 | Bryan K Segedi
Director
|
Grant | 878 | $43.7K |
| Feb 2, 2026 | Calvin G Butler Jr.
Chief Executive Officer
|
Grant | 198.2K | - |
| Feb 2, 2026 | Colette D. Honorable
Officer
|
Grant | 8.7K | - |
| Feb 2, 2026 | Michael A. Innocenzo
Chief Operating Officer
|
Grant | 27.5K | - |
| Feb 2, 2026 | Jeanne M Jones
Officer
|
Grant | 43.4K | - |
| Feb 2, 2026 | Robert A. Kleczynski
Officer
|
Grant | 12.3K | - |
| Dec 31, 2025 | William Paul Bowers
Director
|
Grant | 940 | $41.2K |
| Dec 31, 2025 | Marjorie Rodgers Cheshire
Director
|
Grant | 940 | $41.2K |
| Dec 31, 2025 | David G Dewalt
Director
|
Grant | 940 | $41.2K |
| Dec 31, 2025 | Linda P Jojo
Director
|
Grant | 940 | $41.2K |
| Dec 31, 2025 | Charisse R Lillie
Director
|
Grant | 940 | $41.2K |
| Dec 31, 2025 | Anna S. Richo
Director
|
Grant | 940 | $41.2K |
| Dec 31, 2025 | Matthew C Rogers
Director
|
Grant | 940 | $41.2K |
| Dec 31, 2025 | Bryan K Segedi
Director
|
Grant | 940 | $41.2K |
| Sep 30, 2025 | William Paul Bowers
Director
|
Grant | 950 | $41.3K |
| Sep 30, 2025 | Marjorie Rodgers Cheshire
Director
|
Grant | 950 | $41.3K |
| Sep 30, 2025 | David G Dewalt
Director
|
Grant | 950 | $41.3K |
| Sep 30, 2025 | Linda P Jojo
Director
|
Grant | 950 | $41.3K |
| Sep 30, 2025 | Charisse R Lillie
Director
|
Grant | 950 | $41.3K |
| Sep 30, 2025 | Anna S. Richo
Director
|
Grant | 950 | $41.3K |
| Sep 30, 2025 | Matthew C Rogers
Director
|
Grant | 950 | $41.3K |
| Sep 30, 2025 | Bryan K Segedi
Director
|
Grant | 950 | $41.3K |
| Jun 30, 2025 | William Paul Bowers
Director
|
Grant | 954 | $41.3K |
| Jun 30, 2025 | Marjorie Rodgers Cheshire
Director
|
Grant | 954 | $41.3K |
| Jun 30, 2025 | David G Dewalt
Director
|
Grant | 954 | $41.3K |
| Jun 30, 2025 | Linda P Jojo
Director
|
Grant | 954 | $41.3K |
| Jun 30, 2025 | Charisse R Lillie
Director
|
Grant | 954 | $41.3K |
| Jun 30, 2025 | Anna S. Richo
Director
|
Grant | 954 | $41.3K |
| Jun 30, 2025 | Matthew C Rogers
Director
|
Grant | 954 | $41.3K |
| Jun 30, 2025 | Bryan K Segedi
Director
|
Grant | 954 | $41.3K |
Source: TwelveData, from SEC Form 4 filings
EXC stock forecast: questions people ask
Answered from the figures on this page, as of October 27, 2026.